| Notch Raises $30 Million to Bring Production-Ready AI Agents to Regulated Industries |
Globe Newswire |
03/25 |
07:00 |
| Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026 |
Globe Newswire |
03/25 |
07:00 |
| Winnebago Industries Reports Second Quarter Fiscal 2026 Results |
Globe Newswire |
03/25 |
07:00 |
| Picard Medical Reports Full Year 2025 Financial Results |
Globe Newswire |
03/25 |
07:00 |
| STS Digital Unveils First-to-Market Structured Products Platform, Partnering with Kraken |
Globe Newswire |
03/25 |
07:00 |
| Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development |
Globe Newswire |
03/25 |
07:00 |
| Lightbridge to Serve on Industry Advisory Board of $6 Million DOE-Funded Project with Penn State |
Globe Newswire |
03/25 |
07:00 |
| Westhaven Engages San Diego Torrey Hills Capital for Investor Relations |
Globe Newswire |
03/25 |
07:00 |
| Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease |
Globe Newswire |
03/25 |
07:00 |
| INVESTOR DEADLINE: monday.com Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces |
Globe Newswire |
03/25 |
07:00 |
| NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset |
Globe Newswire |
03/25 |
07:00 |
| C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma |
Globe Newswire |
03/25 |
07:00 |
| Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval |
Globe Newswire |
03/25 |
07:00 |
| Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights |
Globe Newswire |
03/25 |
07:00 |
| Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc. |
Globe Newswire |
03/25 |
07:00 |
| YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs |
Globe Newswire |
03/25 |
06:55 |
| Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) |
Globe Newswire |
03/25 |
06:48 |
| Back to the Roots Unveils Comprehensive Organic Soil Collection, Now Available Nationwide |
Globe Newswire |
03/25 |
06:30 |
| PDD Holdings Announces Fourth Quarter 2025 and Fiscal Year 2025 Unaudited Financial Results |
Globe Newswire |
03/25 |
06:30 |
| CWH Lawsuit: Camping World Accused of Misrepresentations about its Inventory Management in Securities Fraud Class Action – Investors Notified to Contact BFA Law by May 11 |
Globe Newswire |
03/25 |
06:18 |
| DRVN Lawsuit: Driven Brands Accused of Misrepresentations about its Financials in Securities Fraud Class Action – Investors Notified to Contact BFA Law by May 8 |
Globe Newswire |
03/25 |
06:18 |
| SMR Lawsuit: NuScale Power Accused of Misrepresentations about ENTRA1 in Securities Fraud Class Action – Investors Notified to Contact BFA Law by April 20 |
Globe Newswire |
03/25 |
06:18 |
| PLUG Lawsuit: Plug Power Accused of Misrepresentations about its DOE Funding in Securities Fraud Class Action – Investors Notified to Contact BFA Law by April 3 |
Globe Newswire |
03/25 |
06:17 |
| Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026 |
Globe Newswire |
03/25 |
06:15 |
| Kyivstar Subsidiary Uklon Expands Product Ecosystem with Bus Ticket Purchasing |
Globe Newswire |
03/25 |
06:00 |
